Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 11 Issue 11, November 2015

There are a number of drugs in use that are effective against strains of the human pathogen methicillin-resistant Staphylococcus aureus, or MRSA (cells are shown on the cover), but considerations such as antibiotic resistance and cost have highlighted the need for new drugs as well as new therapeutic combinations. Gonzales et al. now show that triple combinations of the clinically useful and proven antibiotics meropenem, piperacillin and tazobactam are synergistic against MRSA through a mechanism involving allostery-based synergy and collateral sensitivity, and can thus be applied at low doses, leading to less resistance. Cover art by Erin Dewalt, based on artwork from Gautam Dantas. Article, p855; News & Views p832

Commentary

  • Protein kinases have emerged as one of the most successful families of drug targets. To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes. Here we discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.

    • Susanne Müller
    • Apirat Chaikuad
    • Stefan Knapp
    Commentary

    Advertisement

  • A 'chemical biology of cellular membranes' must capture the way that mesoscale perturbations tune the biochemical properties of constituent lipid and protein molecules and vice versa. Whereas the classical paradigm focuses on chemical composition, dynamic modulation of the physical shape or curvature of a membrane is emerging as a complementary and synergistic modus operandi for regulating cellular membrane biology.

    • Lars Iversen
    • Signe Mathiasen
    • Dimitrios Stamou
    Commentary
Top of page ⤴

Q&A

  • We asked a collection of chemical biologists: “What advice would you give to a junior scientist interested in pursuing a career in chemical biology?”

    Q&A
Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • The long-awaited crystal structure of the Varkud satellite (VS) ribozyme dimer provides atomic-level insights into how the VS ribozyme folds and catalyzes RNA circularization during rolling circle replication, as well as revealing convergent evolution used by RNAs to catalyze an SN2 reaction.

    • Zhensheng Zhong
    • Gang Chen
    News & Views
  • Multiple mitochondrial components generate reactive oxygen species (ROS), but separating the consequences of each ROS-generating source from overall mitochondrial health is challenging. A new class of small-molecule inhibitors that selectively block ROS generation from one of the most active sources may provide a new approach toward achieving that goal.

    • Bryan C Dickinson
    News & Views
  • Meropenem/piperacillin/tazobactam is a triple β-lactam combination that kills MRSA in vitro and in a mouse model through a novel synergistic mechanism of action. Similar activity for other carbapenem/β-lactam combinations suggests that MRSA infections might be treatable with combinations of established β-lactams currently classified as ineffective against MRSA.

    • Karen Bush
    News & Views
Top of page ⤴

Brief Communication

  • High-throughput chemical screening identified several groups of compounds that selectively block superoxide production from the outer Q-binding site of mitochondrial complex III and protect against ROS-induced oxidative stress in pancreatic β cells.

    • Adam L Orr
    • Leonardo Vargas
    • Martin D Brand
    Brief Communication
Top of page ⤴

Article

  • Crystal structures of the full-length VS ribozyme show a domain-swapped dimer that reveals potential mechanisms for cis and trans processing, and suggest convergent evolution in the active site motifs across multiple ribozymes.

    • Nikolai B Suslov
    • Saurja DasGupta
    • Joseph A Piccirilli
    Article
  • Structural and biochemical investigations of a xylosyltransferase in complex with a domain from its substrate Notch inform on the catalytic mechanism and the conformational rearrangements needed for substrate binding, while genetic analysis poses new questions in cancer biology.

    • Hongjun Yu
    • Megumi Takeuchi
    • Hideyuki Takeuchi
    Article
  • The serine protease HTRA1 utilizes a "disintegration" mechanism involving its flexible PDZ domains to first loosen tau amyloid fibrils and subsequently disintegrating the fibrillar core structure for efficient proteolytic degradation.

    • Simon Poepsel
    • Andreas Sprengel
    • Michael Ehrmann
    Article
  • Gain of function mutations in isocitrate dehydrogenase 1 (IDH1) have been detected in cases of acute myeloid leukemia (AML). The application of an allosteric IDH1 inhibitor in AML cells promotes blast differentiation and restores DNA cytosine methylation patterns.

    • Ujunwa C Okoye-Okafor
    • Boris Bartholdy
    • Ulrich Steidl
    Article
Top of page ⤴

Erratum

Top of page ⤴

Corrigendum

Top of page ⤴

Search

Quick links